N-Methyl Cyclazodone (N-Cyclopropyl-N-Methyl-Pemoline) is a stimulant derived from pemoline. It is approximately three to five times more potent than pemoline. According to patents filed by the inventors, N-Methyl Cyclazodone exhibited much more potent central nervous system stimulating and anorexigenic properties than pemoline. The patent also claims it to have favorable therapeutic index and margin of safety compared to similar compounds.
The related compound, pemoline, is considered dopaminergic, but its precise method of action hasn’t been definitively determined. Pemoline has minimal affinity for norepinephrine receptors and therefore has minimal sympathomimetic side effects (i.e. tremor, headache, dry mouth, etc) compared with typical dopaminergic stimulants, such as methylphenidate and amphetamines.
Furthermore, anecdotal evidence has hinted that pemoline and some related compounds might exhibit cognitive enhancement or nootropic characteristics.
N-Methyl Cyclazodone powder (1g)
This product has not been evaluated by the FDA and is not intended to diagnose, cure, or prevent any disease.
Safety Information: Keep this product out of the reach of children. This product is not a dietary supplement. It is a research compound, sold as a raw material. It may result in adverse effects if improperly handled or consumed. This product is for use and handling only by persons with the knowledge and equipment to safely handle this material.
Cymnootropics.com can’t be held responsible for any adverse effects that may arise from improper handling and/or consumption of this product.
Subscribe and receive news about our special sales and coupons